Thermo Fisher Scientific Inc. beat EPS estimates 95% of the time across 20 reported quarters (19 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $5.71 | $6.03 | +5.6% | Beat |
| Q12026 FY2026 | $5.20 | $5.44 | +4.6% | Beat |
| Q42025 FY2025 | $6.43 | $6.57 | +2.2% | Beat |
| Q42024 FY2024 | $5.94 | $6.10 | +2.7% | Beat |
| Q42023 FY2023 | $5.64 | $5.67 | +0.5% | Beat |
| Q3 FY2023 | $5.61 | $5.69 | +1.4% | Beat |
| Q2 FY2023 | $5.43 | $5.15 | -5.2% | Miss |
| Q1 FY2023 | $4.95 | $5.03 | +1.6% | Beat |
| Q42022 FY2022 | $5.19 | $5.40 | +4.0% | Beat |
| Q32022 FY2022 | $4.78 | $5.08 | +6.3% | Beat |
| Q22022 FY2022 | $4.99 | $5.51 | +10.4% | Beat |
| Q12022 FY2022 | $6.18 | $7.25 | +17.3% | Beat |
Back to TMO overview · TMO holders · TMO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.